SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-074304
Filing Date
2015-10-06
Accepted
2015-10-06 15:12:21
Documents
1
Period of Report
2015-10-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 16633
  Complete submission text file 0001209191-15-074304.txt   17973
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Issuer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5425 WISCONSIN AVENUE, SUITE 800 CHEVY CHASE MD 20815
Business Address
Florence Anthony A. Jr. (Reporting) CIK: 0001559827 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37566 | Film No.: 151145981